StockData
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. (SLGL) stock

SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$52.83−2.13 (-3.88%)

Close on Nov 17, 2026Market cap $147.19MP/E –Yield –

Sol-Gel Technologies r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $22.80M, up 28.1% from the year before. Over ten years it grew 12.2% a year on average. The highest annual figure on record is $40.58M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$22.80M+28.1%
FY2024Dec 31, 2024$17.80M-24.4%
FY2023Dec 31, 2023$23.54M+85.6%
FY2022Dec 31, 2022$12.68M-37.8%
FY2021Dec 31, 2021$20.38M-27.0%
FY2020Dec 31, 2020$27.91M-31.2%
FY2019Dec 31, 2019$40.58M+44.2%
FY2018Dec 31, 2018$28.15M+9.1%
FY2017Dec 31, 2017$25.81M+51.6%
FY2016Dec 31, 2016$17.02M+137.0%
FY2015Dec 31, 2015$7.18M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.72M+56.3%
Q2 FY2025Jun 30, 2025$4.65M-33.0%
Q2 FY2024Jun 30, 2024$2.44M-62.2%
Q2 FY2023Jun 30, 2023$5.31M-53.6%
Q2 FY2022Jun 30, 2022$2.38M-59.1%
Q2 FY2021Jun 30, 2021$6.93M–
Q2 FY2020Jun 30, 2020$6.45M–
Q2 FY2019Jun 30, 2019$11.44M–
Q2 FY2018Jun 30, 2018$5.82M–

More Sol-Gel Technologies figures

See a number that looks wrong?